There are two main ways for bacteria to withstand the effects of
an antibiotic:
- To stop the antibiotic from reaching its target at a high
enough concentration
- To modify or bypass the target that the antibiotic acts on
Over time bacteria have evolved many different antibiotic
resistance strategies to accomplish this.
Antibiotic resistance mechanisms
1. Stop the antibiotic from reaching its target
- Pump the antibiotic out from the bacterial cell. Bacteria can
produce pumps that sit in their membrane or cell wall. These
so-called efflux pumps are very common in bacteria and can
transport a variety of compounds such as signal molecules and
nutrients. Some of these pumps can also transport antibiotics out
from the bacterium, in this way lowering the antibiotic
concentration inside the bacterial cell. In some cases mutations in
the bacterial DNA can make the bacteria produce more of a certain
pump, which in turn increases resistance.
- Decrease permeability of the membrane that surrounds the
bacterial cell. Certain changes in the bacterial membrane make it
more difficult to pass through. In this way, less of the antibiotic
gets into the bacteria.
- Destroy the antibiotic. There are bacterial enzymes that can
inactivate antibiotics. One example is β-lactamase that destroys
the active component (the β-lactam ring) of penicillins, extremely
important antibiotics for treating human infections. In later
years, bacteria that produce extended-spectrum β-lactamases, so
called ESBL-producing bacteria, have become a major problem. They
can degrade a wide spectrum of β-lactam antibiotics, sometimes also
the last resort drugs available for infections with these
bacteria.
- Modify the antibiotic. Bacteria can sometimes produce enzymes
that are capable of adding different chemical groups to
antibiotics. This in turn prohibits binding between the antibiotic
and its target in the bacterial cell.
Antibiotic resistance strategies in bacteria
2. Modify or bypass the target of the antibiotic[
- Camouflage the target. Changes in the composition or structure
of the target in the bacterium (resulting from mutations in the
bacterial DNA) can stop the antibiotic from interacting with the
target. Alternatively, the bacteria can add different chemical
groups to the target structure, in this way shielding it from the
antibiotic.
- Express alternative proteins. Some bacteria are able to produce
alternative proteins that can be used instead of the ones that are
inhibited by the antibiotic. For example, the bacterium
Staphylococcus aureus can acquire the resistance gene
mecA and produce a new penicillin-binding protein. These
proteins are needed for bacterial cell wall synthesis and are the
targets of β-lactam antibiotics. The new penicillin-binding protein
has low affinity to β-lactam antibiotics and is thus resistant to
the drugs, and the bacteria survive treatment. This type of
resistance is the basis in MRSA (methicillin-resistant
Staphylococcus aureus).
- Reprogram target. Sometimes bacteria can produce a different
variant of a structure it needs. For example, Vancomycin-resistant
bacteria make a different cell wall compared to susceptible
bacteria. The antibiotic is not able to interact as well with this
type of cell wall.
Some bacteria are naturally resistant to certain antibiotics.
Imagine for example an antibiotic that destroys the cell wall of
the bacteria. If a bacterium does not have a cell wall, the
antibiotic will have no effect. This phenomenon is called intrinsic
resistance. When a bacterium that was previously susceptible to an
antibiotic evolves resistance it is called acquired resistance.